MeiHua Holdings Group (600873) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
30 Oct, 2026Executive summary
Q3 revenue fell 3.58% YoY to RMB 5.72bn; net profit attributable to shareholders dropped 96.00% to RMB 50.3m, reflecting lower product gross profit.
9M revenue declined 1.42% YoY to RMB 17.96bn; net profit fell 76.46% to RMB 712.2m.
Financial highlights
Q3 total profit was RMB 79.0m, down 94.16% YoY; adjusted for non-recurring items, attributable net profit was a loss of RMB 16.6m.
9M operating profit was RMB 2.66bn; total profit was RMB 909.4m, down 73.58% YoY, and attributable net profit was RMB 712.2m.
9M adjusted attributable net profit was RMB 434.7m, down 78.48% YoY; basic and diluted EPS were RMB 0.25, down 76.42%.
Market and industry conditions
Lower prices for threonine, lysine, MSG and other key products weighed on revenue, while higher raw-material prices compressed margins.
Q3 gross margin fell to 8.01% from 17.29% YoY; 9M gross margin declined to 11.36% from 21.26%.
Latest events from MeiHua Holdings Group
- Net profit fell 62.56% year-over-year on flat revenue, with margins pressured by weak product prices.600873
Q2 2026 - Net profit surged 19.72% on Kyowa gains, despite a 3.43% revenue drop and industry headwinds.600873
Q4 2025 - Net profit dropped 88% year-over-year as lower product prices hit revenue and margins.600873
Q1 2026 - Q3 net profit jumped 141% on acquisition gains, but core profit fell as product prices dropped.600873
Q3 2025 - Net profit surged 19.96% to RMB 1.77 billion despite a slight revenue decline.600873
Q2 2025 - Q3 net profit dropped 33.96% on lower product prices; share repurchase and dividend announced.600873
Q3 2024 - Net profit grew 7.51% to ¥1.47B despite a 6.96% revenue drop, driven by cost control.600873
H1 2024 - Revenue and profit declined on lower prices, but global expansion and R&D accelerated.600873
Q4 2024 - Net profit jumped 35.52% in Q1 2025, driven by higher sales and lower costs.600873
Q1 2025